Brought to you by:
The top 10 most popular Vascular Specialist stories of February 2024
In February, the most read stories from Vascular Specialist include a study of metformin and its potential as the first-ever medical treatment that can manage aneurysm disease; the SVS Sub-Section on Outpatient and Office Vascular Care (SOOVC) release the highly anticipated…
Endologix initiates postmarket study of the Detour system
Endologix has announced the initiation of the Percutaneous transmural arterial bypass (PTAB)1 postmarket study. This study marks the beginning of a comprehensive postmarket study aimed at evaluating the real-world performance of the Detour system in patients undergoing treatment for long…
Trial assessing AI-powered tissue microsensor technology in PAD begins enrollment
Sensome has announced enrollment of the first patients into a feasibility clinical study using the Clotild smart guidewire in peripheral arterial disease (PAD). Clotild was designated a breakthrough medical device for use in brain arteries by the Food and Drug Administration (FDA)…
Breakthrough Device designation granted for Efemoral scaffold system designed to treat CLTI
Efemoral Medical has announced the granting of Food and Drug Administration (FDA) Breakthrough Device status for its novel Efemoral vascular scaffold system (EVSS) designed to treat de novo or restenotic lesions of the infrapopliteal arteries in patients with chronic limb-threatening ischemia (CLTI).…
The top 10 most popular Vascular Specialist stories of January 2024
In January, the most read stories from Vascular Specialist include a U.S. Aortic Research Consortium analysis of F/BEVAR preoperative risk factors in AAAs/TAAAs; a reflection on lessons learnt one year on from BEST-CLI; Southern Vascular’s election of its first female…
‘Get a Pulse on PAD’: Multi-society public awareness campaign launched
The Society for Vascular Surgery (SVS), in partnership with three other medical societies operating in the vascular disease space that form the PAD Pulse Alliance, is taking part in a peripheral arterial disease (PAD) public awareness campaign called “Get a…
UK MHRA update: Paclitaxel-coated device increased mortality risk is withdrawn for PAD
Following a review, the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) has updated guidance on the use of paclitaxel-coated devices stating that such devices can be considered for the treatment of peripheral arterial disease (PAD), including intermittent claudication and critical…
Serration angioplasty associated with reduced recoil in infrapopliteal arteries compared with plain balloon angioplasty
A study comparing the extent of early infrapopliteal recoil after serration and plain balloon angioplasty has found the former produces “substantially less” arterial recoil in the treatment of these lesions and has demonstrated “technical feasibility” in measuring early recoil using…
International collaboration unveils updated PAD guidelines in diabetic foot ulcers
The International Working Group on the Diabetic Foot (IWGDF), the European Society for Vascular Surgery (ESVS) and the Society for Vascular Surgery (SVS) have jointly released updated guidelines for the diagnosis, prognosis and management of peripheral arterial disease (PAD) in…
First procedures announced in study of novel peripheral IVL system
FastWave Medical has announced the successful completion of enrollment for its first-in-human (FIH) study with the company’s peripheral intravascular lithotripsy (IVL) technology. The prospective, single-arm study aims to assess the safety and performance of FastWave’s IVL system in patients with…